NYSE | TSX: ACB
EDMONTON, AB, July 6, 2020 /CNW/ - Aurora Cannabis Inc.
(the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB),
the Canadian company defining the future of cannabinoids worldwide,
today announced that Miguel Martin,
President of Aurora USA and head
of Reliva, LLC ("Reliva"), has been appointed Chief
Commercial Officer of Aurora, effective immediately. Mr. Martin
will replace Darren Karasiuk who has
held this position at Aurora since February
2019.
"This appointment allows us to take full advantage of Miguel's
depth of international CPG experience to drive Aurora's revenues
and brand strength in our global core markets," said Michael Singer, Executive Chairman and Interim
CEO of Aurora. "Miguel has a proven track record of running
profitable global sales and marketing teams in complex, highly
regulated industries that are adjacent to cannabis. His new role at
Aurora is indicative of our commitment to combining sales and
marketing excellence with driving profitability in our core
businesses."
Mr. Singer continued, "On behalf of our Board of Directors and
management team, I would like to thank Darren for his invaluable
contributions to the development of Aurora's commercial strategy."
Mr. Karasiuk added, "I am proud of my accomplishments at Aurora,
most notably leading an incredibly dedicated and talented team that
has been able to achieve leading market share in Canada and abroad."
About Miguel Martin
Mr. Martin is a 25-year consumer packaged goods industry veteran
having joined Aurora from Reliva where he served as Chief Executive
Officer. He became President of Aurora USA upon closing of the Company's acquisition
of Reliva in May 2020. Prior to
Reliva, Mr. Martin was the President of Logic Technology, one of
the largest manufacturers of electronic cigarettes. He also held
the positon of Senior Vice President and General Manager of Altria
Sales & Distribution. Mr. Martin has deep experience operating
in highly regulated industries which will be very additive to
Aurora's portfolio of high quality, rigorously tested and compliant
cannabinoid product formats.
About Aurora
Aurora is a global leader in the cannabis industry serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis dedicated to helping people improve their lives.
The Company's brand portfolio includes Aurora, Aurora Drift, San
Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler,
Reliva CBD and ROAR Sports. Providing customers with innovative,
high-quality cannabis products, Aurora's brands continue to break
through as industry leaders in the medical, performance, wellness
and recreational markets wherever they are launched. For more
information, please visit our website at www.auroramj.com.
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and is a constituent of the S&P/TSX Composite
Index.
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements").
Forward-looking statements are frequently characterized by words
such as "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain
events or conditions "may" or "will" occur. These forward-looking
statements are only predictions. Various assumptions were used in
drawing the conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions, estimates and
assumptions of management in light of management's experience and
perception of historical trends, current conditions and expected
developments at the date the statements are made, such as current
and future market conditions, the current and future regulatory
environment and future approvals and permits. Forward-looking
statements are subject to a variety of risks, uncertainties and
other factors that management believes to be relevant and
reasonable in the circumstances could cause actual events, results,
level of activity, performance, prospects, opportunities or
achievements to differ materially from those projected in the
forward-looking statements, including the risks associated with:
entering the U.S. market, the ability to realize the anticipated
benefits associated with the acquisition of Reliva, achievement of
Aurora's business transformation plan, general business and
economic conditions, changes in laws and regulations, product
demand, changes in prices of required commodities, competition, the
effects of and responses to the COVID-19 pandemic and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 10, 2019 (the "AIF") and filed
with Canadian securities regulators available on the Company's
issuer profile on SEDAR at www.sedar.com and filed with and
available on the SEC's website at www.edgar.gov. The Company
cautions that the list of risks, uncertainties and other factors
described in the AIF is not exhaustive and other factors could also
adversely affect its results. Readers are urged to consider the
risks, uncertainties and assumptions carefully in evaluating the
forward-looking statements and are cautioned not to place undue
reliance on such information. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable securities law.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-appoints-international-consumer-packaged-goods-executive-miguel-martin-as-chief-commercial-officer-301088236.html
SOURCE Aurora Cannabis Inc.